We give you a written timeline estimate for your case before you commit.Ask about Kisunla
Is Kisunla available in Saudi Arabia? Status, route and cost
A plain answer for families in Saudi Arabia, checked against FDA, regulator and manufacturer sources on 17 October 2026.
Reviewed by the Reserve Meds clinical operations team on 17 October 2026.
Is Kisunla available in Saudi Arabia?
Yes. Kisunla is registered in Saudi Arabia and listed in SFDA's public Drugs List (checked 17 October 2026). It is an anti-amyloid antibody for early symptomatic Alzheimer's disease. Your specialist can prescribe it through a hospital that stocks it, so no named-patient import is normally needed.
- Registration: Registered in Saudi Arabia: it is listed in the SFDA public Drugs List (entry 1108260251), checked 17 October 2026.
- Access route: Prescription through a hospital in Saudi Arabia that stocks it.
- Who acts: your treating specialist and hospital; the hospital pharmacy orders it.
- Timeline: We give you a written timeline estimate for your case before you commit.
- Medicine price: quote on request. Every case gets a written custom quote before you commit.
Status in Saudi Arabia, with dates
- Kisunla is listed in the SFDA public Drugs List (entry 1108260251), checked 17 October 2026. (source)
What Kisunla is
Kisunla (donanemab) is made by Eli Lilly. The US FDA approved Kisunla on 2 July 2024 for early symptomatic Alzheimer's disease, including mild cognitive impairment and mild dementia, with confirmed amyloid pathology.
How it is given: An intravenous (IV) infusion of about 30 minutes every four weeks: 700 mg for the first three doses, then 1,400 mg. Doctors can consider stopping once amyloid plaques fall to minimal levels on a PET scan. It has a boxed warning for amyloid-related imaging abnormalities (ARIA), which can be serious and, rarely, fatal.
How access works in Saudi Arabia
Because Kisunla is registered, a specialist can prescribe it through a hospital that stocks it, and the hospital pharmacy orders it through the local supply channel. A named-patient import is meant for medicines that are not registered, so it is not the usual route.
If your hospital cannot obtain it, ask the hospital pharmacy why. The reason may be stock, the hospital formulary or funding, and each has a different answer.
Public lists can lag behind decisions, so the hospital pharmacy confirms the current status before treatment is planned.
Who does what
- Your treating specialist decides whether Kisunla is right for the patient and writes the referral or prescription.
- The hospital or treatment center orders and gives the medicine, and is responsible for using it safely.
- The Saudi Food and Drug Authority (SFDA) registers medicines and decides on any import request for a medicine that is not registered.
- Eli Lilly makes Kisunla and decides where it can be supplied.
- Reserve Meds helps your family understand the steps, organizes records and communication, and, where an import is needed, arranges US supply through our licensed wholesale partner. We do not give medical advice.
Documents you will usually need
- Confirmation of amyloid (amyloid PET scan or spinal fluid test) and a recent brain MRI
- A prescription or treatment plan from the specialist, with the dose and duration
- Recent clinic notes and laboratory results
- For an import request: the hospital's request form, its signed declaration of responsibility, written patient consent, and proof of the US FDA approval (we can supply the US prescribing information)
Steps
- Assessment. Your specialist confirms that the patient fits the approved use and orders the needed tests.
- Prescription. The specialist prescribes it at a hospital that stocks it.
- Supply. The hospital pharmacy orders it through the local supply channel.
- Treatment. The patient starts treatment with the monitoring the label requires.
Timeline and cost
We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines.
Medicine price: quote on request. Your total cost depends on the dose, travel or shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate access to FDA-approved medicines only. We help your family understand the route, organize records and communication with the hospital or center, and, where an import is approved, arrange US supply and shipping. We do not prescribe, and we do not decide what the regulator or a treatment center approves.
Ask about Kisunla in Saudi Arabia
Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is Kisunla registered in Saudi Arabia?
Yes. Kisunla is registered in Saudi Arabia and listed in SFDA's public Drugs List (checked 17 October 2026). Public lists can lag behind registration decisions, so the hospital pharmacy confirms the status in SFDA's system before anything is filed.
How do patients in Saudi Arabia get Kisunla?
It is an anti-amyloid antibody for early symptomatic Alzheimer's disease. Your specialist can prescribe it through a hospital that stocks it, so no named-patient import is normally needed.
How long does it take to get Kisunla in Saudi Arabia?
We give you a written timeline estimate for your case before you commit. The treating center, the regulator and the manufacturer set their own timelines, and we tell you honestly what depends on them.
How much does Kisunla cost?
Medicine price: quote on request. Your total cost, including any travel, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.
Can Kisunla be sent to our home?
No. Kisunla goes to the hospital that will give it, never to a home address. Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We are not a pharmacy.
Sources
Checked on 17 October 2026. Regulator rules and lists change. Your hospital pharmacy or treatment center confirms the current position before anything is filed.